Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPB-111001 in advanced cancers
NCT02042885Phase 2Terminated
- Sponsor
- Otsuka Holdings
- Start
- Jan 2014
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of OPB-111001 in prostate cancer (PCa), salivary gland cancer (SGC), endometrial cancer (EC), Cervical Cancer (CC), breast cancer, sponsored by Otsuka Holdings. Started Jan 2014; status: terminated.
02
Drugs
OPB-111001
03
Conditions
prostate cancer (PCa)salivary gland cancer (SGC)endometrial cancer (EC)Cervical Cancer (CC)breast cancer
Beyond the preview
Go deeper on NCT02042885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02042885.